Evidence map›Paper›PMID 42427861›Full record

ArticleResearch square2026

Developing a melanoma-skin-on-a-chip integrated with vasculature using an edgeless skin reconstruction approach.

Felikss Rumnieks, Deniz Ornek, Rolando Perez-Lorenzo, Hasan Erbil Abaci

Abstract readPreprint
In one paragraph

Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Felikss RumnieksColumbia University Irving Medical Centre, Department of Dermatology, NY, USA.
Deniz OrnekColumbia University, Department of Biomedical Engineering.
Rolando Perez-LorenzoColumbia University Irving Medical Centre, Department of Dermatology, NY, USA.
Hasan Erbil AbaciColumbia University Irving Medical Centre, Department of Dermatology, NY, USA.

Funding

Tumor Biology and Microenvironment ProgramP30CA013696 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Anil K Rustgi · 1985 to 2026
$115.3M
Geometrical Regulation of Collective Cellular Responses in Three-Dimensional Space and TimeR35GM160480 · NIGMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Hasan Erbil Abaci · 2025 to 2026
$888k
NCI NIH HHS P30 CA013696NIGMS NIH HHS R35 GM160480
6 · The paper itself

Abstract

Melanoma is the most aggressive form of skin cancer, characterized by high metastatic potential and frequent resistance to targeted therapies. Traditional 2D cultures and animal models often fail to accurately mimic the complexity of the human tumor microenvironment (TME). To improve the recapitulation of the cellular and mechanical microenvironmental cues, we bioengineered a melanoma-skin-on-a-chip platform using an edgeless 3D skin reconstruction strategy, which allows for creating mechanically relevant skin microenvironments. The platform integrates a dermis compartment made of primary dermal fibroblasts, human umbilical vein endothelial cells (HUVECs), and melanoma spheroids (generated using MeWo and A375 cell lines), and an epidermis compartment made of differentiated layers of primary keratinocytes. Melanoma spheroids consist of a mixture of melanoma cells, fibroblasts and endothelial cells in collagen droplets, and when incorporated into the engineered dermis, form morphologically heterogeneous structures that mimicked

Indexed as

edgeless skinhuman skin constructsmelanoma modelingtumor microenvironmenttumor vascularization

Identifiers

PMID42427861
PMCPMC13345533

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.